用于人类疾病研究的诱导多能干细胞技术。 - Suppr | 超能文献

相似文献

1

Induced pluripotent stem cell technology for the study of human disease.用于人类疾病研究的诱导多能干细胞技术。

Nat Methods. 2010 Jan;7(1):25-7. doi: 10.1038/nmeth.f.283.

2

Making it personal: the prospects for autologous pluripotent stem cell-derived therapies.个体化治疗：自体多能干细胞衍生疗法的前景

Regen Med. 2016 Jul;11(5):423-5. doi: 10.2217/rme-2016-0057. Epub 2016 Jun 27.

3

iPS cells--alternative pluripotent cells to embryo stem cells.诱导多能干细胞——胚胎干细胞的替代多能细胞。

Sci China Life Sci. 2010 Jan;53(1):154-156. doi: 10.1007/s11427-010-0020-9.

4

Disease-in-a-dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation.培养皿中的疾病：患者特异性诱导多能干细胞技术对再生康复的贡献

Am J Phys Med Rehabil. 2014 Nov;93(11 Suppl 3):S155-68. doi: 10.1097/PHM.0000000000000141.

5

A "season of light" in stem cell research and regenerative medicine: observations on recent developments.干细胞研究与再生医学的“光明季”：对近期进展的观察

ILAR J. 2009;51(1):85-7. doi: 10.1093/ilar.51.1.85.

6

How far are induced pluripotent stem cells from the clinic?诱导多能干细胞离临床应用还有多远？

Ageing Res Rev. 2010 Jul;9(3):257-64. doi: 10.1016/j.arr.2010.03.001. Epub 2010 Apr 1.

7

MicroRNA-induced pluripotent stem cells.微小RNA诱导的多能干细胞。

Malays J Pathol. 2012 Dec;34(2):167-8; author reply 169.

8

Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes?用人诱导多能干细胞进行安全有效的心脏再生治疗：我们应如何制备纯心肌细胞？

Circ Res. 2017 May 12;120(10):1558-1560. doi: 10.1161/CIRCRESAHA.116.310328.

9

Human kidney cell reprogramming: applications for disease modeling and personalized medicine.人类肾脏细胞重编程：疾病建模和个性化医疗的应用。

J Am Soc Nephrol. 2013 Sep;24(9):1347-56. doi: 10.1681/ASN.2012121199. Epub 2013 Aug 15.

10

[Regenerative therapy for post-stroke patients].[中风患者的再生治疗]

Nihon Rinsho. 2016 Apr;74(4):661-5.

引用本文的文献

1

Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons.阳离子碳硅烷树状大分子可预防帕金森病患者特异性多巴胺神经元中异常α-突触核蛋白的积累。

Biomacromolecules. 2021 Nov 8;22(11):4582-4591. doi: 10.1021/acs.biomac.1c00884. Epub 2021 Oct 6.

2

Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs.白细胞介素-17 和 Th17 淋巴细胞直接损害野生型和 FUS-ALS 突变型人诱导多能干细胞中的运动神经元存活。

Int J Mol Sci. 2021 Jul 27;22(15):8042. doi: 10.3390/ijms22158042.

3

Fine-tuning of dual-SMAD inhibition to differentiate human pluripotent stem cells into neural crest stem cells.

本文引用的文献

1

Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.利用患者特异性诱导多能干细胞对家族性自主神经功能异常的发病机制及治疗进行建模。

Nature. 2009 Sep 17;461(7262):402-6. doi: 10.1038/nature08320. Epub 2009 Aug 19.

2

Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases.利用锌指核酸酶有效靶向人类胚胎干细胞和诱导多能干细胞中的表达基因和沉默基因。

Nat Biotechnol. 2009 Sep;27(9):851-7. doi: 10.1038/nbt.1562. Epub 2009 Aug 13.

3

iPS cells produce viable mice through tetraploid complementation.